Mammalian pregnancy is a unique immunological paradox because the fetus, which bears paternal histocompatible antigens which are alien to the maternal immune system can survive normally as an allograft in the mother. Several mechanisms have been proposed to explain fetal acceptance including nonspecific suppression of maternal immunity (1). Previous studies have suggested that factors in pregnant sera play a role in the suppression of maternal immunity (2-9), including sex hormones (2, 3), serum-blocking antibody (4), pregnancy-associated proteins (5), a-fetoprotein (6, 7), and as yet undefined factors. However, none of these have been established as a major factor in the suppressed maternal immunity. Moreover, contradictory results have been recently reported by Smith (8) and Hamilton and Hellstr/Sm (9), who claim that sera from syngeneically or allogeneically pregnant mice do not inhibit the responses of normal lymphocytes to alloantigens. The reasons for these discrepancies are unclear. Other evidence which suggests suppressed maternal immunity during pregnancy includes depressed mixed lymphocyte reactions (10), diminished mitogen responses (6, 11), decreased leukocyte migration (12), and delayed skin graft rejection (13). An increased frequent occurrence of severe viral infection during pregnancy (14) has also been postulated to be related to suppressed maternal immunity. There have, however, been very few reports investigating the antibody response following challenge in pregnant animals. One study (15) reports that the circulating antibody titers to several antigens including sheep erythrocytes (SRBC) t were not significantly altered during pregnancy while we have previously reported a decreased splenic plaque-forming-cell (PFC) response following in vivo immunization of pregnant mice (7).
Mammalian pregnancy is a unique immunological paradox because the fetus, which bears paternal histocompatible antigens which are alien to the maternal immune system can survive normally as an allograft in the mother. Several mechanisms have been proposed to explain fetal acceptance including nonspecific suppression of maternal immunity (1) . Previous studies have suggested that factors in pregnant sera play a role in the suppression of maternal immunity (2-9), including sex hormones (2, 3) , serum-blocking antibody (4), pregnancy-associated proteins (5), a-fetoprotein (6, 7) , and as yet undefined factors. However, none of these have been established as a major factor in the suppressed maternal immunity. Moreover, contradictory results have been recently reported by Smith (8) and Hamilton and Hellstr/Sm (9) , who claim that sera from syngeneically or allogeneically pregnant mice do not inhibit the responses of normal lymphocytes to alloantigens. The reasons for these discrepancies are unclear. Other evidence which suggests suppressed maternal immunity during pregnancy includes depressed mixed lymphocyte reactions (10) , diminished mitogen responses (6, 11) , decreased leukocyte migration (12) , and delayed skin graft rejection (13) . An increased frequent occurrence of severe viral infection during pregnancy (14) has also been postulated to be related to suppressed maternal immunity. There have, however, been very few reports investigating the antibody response following challenge in pregnant animals. One study (15) reports that the circulating antibody titers to several antigens including sheep erythrocytes (SRBC) t were not significantly altered during pregnancy while we have previously reported a decreased splenic plaque-forming-cell (PFC) response following in vivo immunization of pregnant mice (7) .
The present study shows that in vitro IgM antibody synthesis against SRBC is decreased in the pregnant spleen cells compared to controls, and moreover this appears to be mediated by nonspecific splenic suppressor cells. At least two populations of pregnant spleen cells were shown to exert a nonspecific suppressor effect. One is a T lymphocyte and the other a nylon wool-adherent cell present in the B-cell-enriched macrophage-depleted fraction. Pregnant spleen cells cultured in vitro secrete soluble supernate factors which decrease the primary IgM antibody response of normal spleen cells. We were unable to demonstrate suppressor cells in the pregnant lymph node cells of cervical, axillary, and popliteal regions. Finally, mitogen-and antigen-induced lymph node cell proliferative responses including those lymph nodes draining the uterus, were not significantly different in pregnant and control animals.
Materials and Methods
Animals. CBA/J mice were purchased from The Jackson Laboratory, Bar Harbor, Maine, and BALB/c mice from Cumberland View Farm, Clinton, Tenn. Pregnant CBA/J mice were obtained by mating CBA/J female mice to CBA/J male mice (syngeneically pregnant), and to BALB/c male mice (allogeneically pregnant) in our animal facility. The time of pregnancy was determined by examination of vaginal plugs.
In Vivo Antibody Synthesis. Approximately 10-to 13-d pregnant CBA/J mice and age-matched CBA/J female mice were used. 5 X 10 s SRBC were injected i.p. 4 d later spleens were removed and the primary IgM antibody responses against SRBC were studied using Jerne's hemolytic plaque assay as modified by Cunningham and Szenberg (16) .
To study the antibody responses of lymph node cells, 10 × 10 v SRBC were injected into both footpads of control or pregnant mice. 4 d later the popliteal lymph nodes were removed and the PFC assay performed. The assay was done on individual mice, and the mean and SE obtained.
In Vitro Antibody Response. Approximately 15-d pregnant and age-matched control CBA/J female mice were employed for the in vitro antibody responses and the mitogen-induced proliferative responses. 10 × 106 spleen cells were cultured with 10 × 10 ~ SRBC in a Marbrook chamber for 4 d at 37°C in a humidified atmosphere of 5% COs and 95% air. Culture media consisted of RPMI-1640 supplemented with 5% heat-inactivated fetal calf serum (FCS) and horse serum, 5 × 10 -6 M 2-mercaptoethanol, 100 U/ml of penicillin, 100/~g/ml of streptomycin, and 2 mM glutamine (all supplements from Grand Island Biological Co., Grand Island, N.Y.). The cultures were performed on lymph node and spleen cells from individual mice or on pools of 4-5 mice. The mean numbers of PFC per culture were calculated from the result of triplicate cultures.
Mitogen-mduced Blastogenesis. 2 × 10 n spleen cells or lymph node cells were placed into each well of a fiat-bottomed microtiter plate (No. 3042, Falcon Plastics, Div. of Becton, Dickinson & Co., Oxnard, Calif.) and were routinely cultured in the presence of an optimal dose (4.0/zg/ ml) of phytohemagglutinin (PHA; The Wellcome Research Laboratories, Beckenham, Kent, England), or 50/~g/ml of Escherichia coli, lipopolysaccharide (LPS; Difco Laboratories, Detroit, Mich.). However, various doses of PHA (1, 2, 4, and 8 p.g/mt) and LPS (10, 20, 50 , and 100 #g/ml) have also been employed to be certain that there was no shift in the dose response curve. The culture media consisted of the same components as indicated for the in vitro antibody response except that the serum supplement was 5% heat-inactivated FCS. The cultures were maintained at 37°C for 3 d in a humidified atmosphere of 5% CO2 and 95% air. t6 h before harvesting, 1 /tCi of [3H]methyl thymidine in 20 pl of RPMI-1640 was added to each well. The cells were harvested on a glass fiber paper using a Mash II harvester (Microbiological Associates, Walkersville, Md.) and dissolved in 2 ml of Aquasol (New England Nuclear, Boston, Mass.). The radioactivity was then determined using a Beckman scintillation counter (Beckman Instruments, Fullerton, Calif.). All determinations were performed in triplicate and the data is expressed as the mean cpm +--SE.
Antigen-induced Lymph Node Cell Proliferation. Antigen-induced lymph node cell (LNC) proliferative assay was performed using a modification of the method described by Alkan (17) . Briefly, 100/Lg of ovalbumin (OVA; Sigma Chemical Co., St. Louis, Mo.) emulsified in H37Ra complete adjuvant (Difco Labs) was injected into -10-to 12-d pregnant CBA/J mice and agematched control mice at three different sites: anterior and posterior footpads, and s.c. in the base of the tail. 7 d later draining lymph nodes of these three immunization sites were separately obtained from axillary, popliteal, and para-aortic (uterus-draining) regions, and 4 × l0 s sensitized LNCs from each region were cultured in vitro with either 250 pg/ml of OVA or 50 pg/ml of purified protein derivative (PPD; Connaught Laboratories, Toronto, Canada). 4 d later DNA synthesis was measured as described in mitogen-induced blastogenesis.
Cell Preparation. Single cell suspensions of spleen and lymph node cells were prepared by gentle teasing and passing the cells through a screen mesh. After being washed twice in cold Hank's balanced salt solution (BSS), the cells were resuspended in culture media. In some experiments erythrocytes contained in spleens were lysed using ammonium-chloride-potassium lysing buffer. Nylon-wool-nonadherent T lymphocytes isolated from spleens (subsequently referred to as spleen T cells) were obtained by the method described by Julius et al. (18) . Nylonwool-adherent cells were obtained using a modification of the method described by Handwerger and Schwartz (19) . Briefly, after nonadherent T cells were eluted, the nylon wool column was washed with warm culture media. The nylon wool was then compressed with a plunger and flushed with cold culture media. This process was repeated three to four times and the cells resuspended in culture media. Splenic macrophages were obtained as follows: 10 × 107 spleen cells in 10 ml culture media were plated on 100 × 20-mm plastic Petri dishes (Falcon Plastics) and incubated for 2 h at 37°C. The nonadherent cells were removed, the plates washed with media, and the cells adherent to the dishes were then dislodged by vigorous pipettings using Ca++-free Hank's BSS containing 0.02% EDTA. The cells were washed three times before use. The recovered adherent cell population showed >95% viability by trypan blue exclusion, and contained predominantly macrophages (85-90% as determined by latex ingestion or esterase staining).
Pretreatment with anti-Thy 1.2 serum plus complement was done as follows: ~50 × 106 cells were incubated with a 1:20 dilution of anti-Thy 1.2 serum (AKR anti-C3H thymocyte, purchased from Bionetics Laboratory Products, Litton Bionetics Inc., Kensington, Md.) for 30 min at room temperature. The cells were washed once and resuspended in a 1:10 dilution of guinea pig complement. After incubation at 37°C for 45 min, the cells were washed three times. PHA-and LPS-induced blastogenesis was used to assess the effectiveness of this treatment. All preparations showed a marked diminution of the PHA response and essentially no change in the LPS response. Table I , a significant decrease of the primary IgM antibody response in vivo against SRBC was observed in the pregnant spleen cells, compared to that of the age-matched controls. However, there was no difference in the in vivo response of lymph node cells between the pregnant and control groups. Table II shows the results of the in vitro primary IgM antibody responses. The PFC response of the pregnant spleen cells were two to three times less than those of controls. Similar decreases were obtained with both syngeneically and allogeneically pregnant spleen cells and also in the cultures stimulated with various doses of SRBC (data not shown). The PFC responses in vitro of the lymph node cells from cervical, axillary, and popliteal regions were essentially identical in pregnant and control animals; this experiment was repeated three times with essentially identical results. Table III shows the results of the mitogen-induced blastogenesis of spleen cells and lymph node cells including those of draining lymph nodes of the uterus. The data shows that there was no significant difference between the two groups of mice. Similar results were obtained when various concentrations of mitogens as well as different cell densities in the culture were employed (data not shown). Table IV demonstrates that ovalbumin and PPD-induced lymph node cell proliferation are not significantly altered in pregnant animals.
Results

In Vivo and In Vitro Responses of Pregnant vs. Age-matched Control Mice. As shown in
Is the Low PFC Response of the Pregnant Spleen Cells a Result of Suppressor Cells?
The experiment shown in Fig. 1 was performed in an attempt to determine whether or not suppressor cells were involved in the decreased PFC response of the pregnant spleen cells. Various numbers of spleen cells from ~15-d pregnant or age-matched control mice were added to the normal spleen cell culture containing 10 × 10 n normal spleen cells/chamber, and the mixture cultured with 10 × 10 n SRBC for 4 d. As shown in The assay was performed on individual mice and the mean value obtained from four mice of each group, ). 4 d later the supernatant medium was obtained and centrifuged at 2,000 rpm for 10 min to remove cells. 1 ml of the supernatant medium was added to the inner compartment of a Marbrook chamber containing 1 ml of the cell suspension (10 × 10S/ml) of normal spleen cells. As shown in Table VI , the supernate of the control spleen cells showed a slightly decreased PFC response compared to the addition of fresh culture medium. However, the supernate of pregnant spleen cells was strikingly suppressive compared to that of control spleen cells (P < 0.05) suggesting the secretion of a soluble suppressive factor(s) from pregnant spleen cells. This experiment was repeated four times with essentially identical results. Antigenic stimulations of pregnant spleen cells with SRBC did not appear to alter the production of the factor(s), because the supernatant medium of the culture with SRBC added suppressed to the same degree as that shown in Table  VI .
TABLE V
Suppression of the Normal PFC Responses by Subpopulations of Pregnant Spleen Cells
Discussion
Several recent studies have suggested that suppressor cell activity may be involved in pregnancy-associated decreased immune responses (9, (20) (21) (22) . For example, Clark and MacDermott (20) have presented evidence for the presence of a suppressor cell(s) for paternal antigens in the mixed lymphocyte cultures of the cells from the draining lymph nodes of the uterus, although the type of the suppressor cell(s) was not defined in this study. Adoptive transfer of spleen cells from multiparous mice to virgin recipients has also been reported to induce tolerance to the H-Y antigen in male skin graft and this appears to be mediated by suppressor T cells (21) . Similar suppressor T cells have also been reported in humans (22) . In addition, it has been shown by Hamilton and Hellstr/Sm (9) that the mixtures of lymphocytes from pregnant and virgin mice are less reactive to alloantigen stimulation than the individual cell population alone, suggesting the presence of nonspecific suppressor cells in pregnant mice. Our study has presented evidence for the involvement of suppressor cell activity in the decreased splenic antibody responses of pregnant mice. The primary IgM antibody synthesis against SRBC in vivo as well as in vitro are markedly decreased in the spleen cells of pregnant mice and this decrease of antibody synthesis is probably mediated via nonspecific suppressor cells. This is evidenced by the observation that the addition of pregnant spleen cells to normal spleen cell cultures causes a significant suppression of PFC responses of normal spleen cells. Whether the diminished primary and secondary IgG and IgA splenic antibody responses of pregnant mice previously reported from this laboratory (7) are mediated by suppressor cells has not been explored.
An interesting observation is that the suppressor cell activity in pregnant mice is evident only in spleen cells and not in lymph node cells. Similar observations of the preferential localization of suppressor cells in spleens rather than lymph nodes has been described in animals under conditions of tumor growth (23, 24) , graft vs. host (GVH) reactions (25) , and certain bacterial infections, as well as in animals which have been immunized with a large dose of antigen (26, 27) . It has been suggested that the microenvironment of the spleen may be favorable to the generation and/or trapping of suppressor cells (25) . Gershon et al. (25) have described that under certain experimental conditions immune responses are suppressed by a subpopulation of thymocytes and/or thymus-derived cells. These cells are short-lived Tx cells, continuously being replenished from the thymic cortex, preferentially homing to spleens, and expressing suppressor cell activity there. Perhaps increased mobilization of Ta cells from thymus to spleen may take place during pregnancy resulting in the enrichment of suppressor cells in the pregnant spleen. This could be one of the explanations for the concomitant manifestation of pregnancy-associated thymic atrophy and spleen enlargement. As pointed out by Anderson (28) , thymic atrophy and spleen enlargement similar to those seen during pregnancy also occur in tumorbearing animals in which spleen-seeking thymocytes have been postulated to operate in the immune suppression associated with certain tumors.
We have demonstrated that at least two cell populations are involved in the decreased PFC responses of pregnant spleen cells. One is T cells and the other is a nylon-wool-adherent cell present in the B-cell-enriched macrophage-depleted fraction. Suppression by T cells is abolished by treatment with anti-Thy 1.2 serum plus complement while such treatment does not alter suppression by the nylon-wooladherent cells. This suggests that the nylon-wool-adherent suppressor cells are different from the nylon-wool-adherent T suppressor cells described by Tada (29) . The nylonwool-adherent cells of pregnant mice are still suppressive after macrophages contained in this population are depleted. Thus, the nature of the suppressor cell(s) in the nylonadherent preparations has not been defined, although because B cells represent the majority of cells remaining in the macrophage-depleted Thy 1.2-negative nylon-wool-adherent fraction, suppression by pregnant spleen cells may be in part caused by the B-cell population.
The mechanisms by which the two cell populations of pregnant spleens exert their suppressive activity are unknown. It is possible that these cells act via interaction with each other and/or other types of cells. For example, the nylon-wool-adherent suppressor cells of pregnant mice could affect the T helper cells in a T-B interaction similar to that described in GVH mice (30) . Alternatively, pregnant T cells may secrete soluble factors which in turn inhibit the response of B cells. Our preliminary data suggests that the suppressed PFC responses of normal spleen cells after the addition of pregnant cells may be mediated via a soluble factor(s) released from pregnant spleen cells. However, neither the cells producing the factor nor the target cells producing the factor(s) have as yet been defined. Although most of the suppressive factors contained in pregnant sera have been reported to be the products of the fetus or the placenta, our data suggest the possibility that a suppressive serum factor(s) could be elaborated by suppressor cells in pregnant spleens.
Previous studies have yielded conflicting results regarding mitogen-induced blastogenesis of maternal lymphocytes. The data presented here on the responsiveness of pregnant lymphocytes to mitogens is similar to that by Anderson (28) who has demonstrated that there was little difference between pregnant and control mice. Similarly, antigen-induced proliferation of lymph node cells, including those draining the uterus, are not depressed in pregnant mice. However, some investigators have claimed a significantly decreased response to mitogens in pregnant mice (6) . These discrepancies could result from strain difference of mice, time of pregnancy at which the assay was performed, and the in vitro culture conditions. We believe that a major problem in analyzing the effect of mouse sera on immune reactions is the significant variation in suppressive potency of various pools of normal and pregnant sera. It is essential, therefore, to compare multiple pools of pregnant sera with several pools of age-matched nonpregnant female controls. We also emphasize that the present data has been obtained at one point during pregnancy (~ 15 d) and that studies at different times are necessary. However, we have observed suppression in the primary and secondary splenic PFC response between 10 and 20 d of pregnancy (7), suggesting that similar factors may operate during this time span.
Summary
The primary IgM antibody response to sheep erythrocytes in vivo as well as in vitro is markedly decreased in the spleen cells of pregnant mice, compared to age-matched female controls. Decreased antibody synthesis appears to be mediated by nonspecific suppressor cells, because the addition of pregnant spleen cells to the normal spleen cell cultures causes a significant suppression of plaque-forming-cell responses of the normal spleen cells. Suppressor cell activity was not observed in lymph nodes of pregnant mice. At least two populations of pregnant spleen cells were shown to exert a suppressor cell activity; one is T lymphocytes and the other a nylon-adherent cell present in the B-cell-enriched macrophage-depleted fraction. Pregnant spleen ceils cultured in vitro were shown to secrete a soluble suppressive factor(s) into the supernatant medium.
